Reversal of collateral ventilation using endoscopic polymer foam in COPD patients undergoing endoscopic lung volume reduction with endobronchial valves: A controlled parallel group trial.
Alvin J IngAnand JayapadmanWoo-Veen KimChelsea LyKevin Ho-ShonPaul LilburnAlan M CarewBenjamin J H NgTajalli SaghaieJonathan P WilliamsonPublished in: Respirology (Carlton, Vic.) (2022)
EPF successfully reverses CV in severe COPD patients with a left oblique fissure that is 80%-95% complete. Following EBV, outcomes are similar to patients with complete fissures undergoing ELVR with EBV alone. EPF therapy to reverse CV potentially increases the number of COPD patients suitable for ELVR with minimal adverse reactions.
Keyphrases
- chronic obstructive pulmonary disease
- ultrasound guided
- lung function
- patients undergoing
- end stage renal disease
- epstein barr virus
- chronic kidney disease
- diffuse large b cell lymphoma
- newly diagnosed
- ejection fraction
- clinical trial
- peritoneal dialysis
- prognostic factors
- stem cells
- cystic fibrosis
- emergency department
- heart failure
- phase iii
- patient reported outcomes
- type diabetes
- intensive care unit
- bone marrow
- adipose tissue
- fine needle aspiration
- coronary artery disease
- acute respiratory distress syndrome
- phase ii
- mechanical ventilation
- electronic health record
- transcatheter aortic valve replacement